{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:47:50Z","timestamp":1784238470109,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10620-023-08016-x","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T03:27:49Z","timestamp":1688527669000},"page":"3557-3561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3032-448X","authenticated-orcid":false,"given":"Nisha B.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Guerrero","family":"Vinsard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G.","family":"Kattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda V.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"8016_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1447-0756.2007.00551.x","volume":"33","author":"H Seki","year":"2007","unstructured":"Seki H, Matuoka K, Inooku H, Takeda S. TNF-alpha from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line. J Obstet Gynaecol Res. 2007;33:408\u2013416.","journal-title":"J Obstet Gynaecol Res."},{"issue":"2","key":"8016_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1443-1661.2010.01049.x","volume":"23","author":"T Sakamoto","year":"2011","unstructured":"Sakamoto T, Saito Y, Nakajima T, Matsuda T. Comparison of magnifying chromoendoscopy and narrow-band imaging in estimation of early colorectal cancer invasion depth: a pilot study. Dig Endosc. 2011;23:118\u2013123.","journal-title":"Dig Endosc."},{"issue":"1","key":"8016_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","volume":"94","author":"H-CSM Reinecker","year":"2008","unstructured":"Reinecker H-CSM, Witthoeft T. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1\u03b2 by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn\u2019s disease. Clin Exp Immunol. 2008;94:174\u2013181.","journal-title":"Clin Exp Immunol."},{"key":"8016_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/908649","volume":"2010","author":"N Vitoratos","year":"2010","unstructured":"Vitoratos N, Economou E, Iavazzo C, Panoulis K, Creatsas G. Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediators Inflamm. 2010;2010:908649.","journal-title":"Mediators Inflamm."},{"issue":"2","key":"8016_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ajg.2010.464","volume":"106","author":"U Mahadevan","year":"2011","unstructured":"Mahadevan U, Cucchiara S, Hyams JS et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn\u2019s and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011;106:214\u2013223.","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"8016_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ajg.2008.71","volume":"104","author":"SV Kane","year":"2009","unstructured":"Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009;104:228\u2013233.","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"8016_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","volume":"9","author":"CJ van der Woude","year":"2015","unstructured":"van der Woude CJ, Ardizzone S, Bengtson MB et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis. 2015;9:107\u2013124.","journal-title":"J Crohns Colitis."},{"issue":"3","key":"8016_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","volume":"11","author":"U Mahadevan","year":"2013","unstructured":"Mahadevan U, Wolf DC, Dubinsky M et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013;11:286\u2013292.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"8016_CR9","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","volume":"156","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology 2019;156:1508\u20131524.","journal-title":"Gastroenterology"},{"issue":"3","key":"8016_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","volume":"150","author":"GC Nguyen","year":"2016","unstructured":"Nguyen GC, Seow CH, Maxwell C et al. The Toronto Consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 2016;150:734\u2013757.","journal-title":"Gastroenterology"},{"issue":"4","key":"8016_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/apt.12833","volume":"40","author":"M Seirafi","year":"2014","unstructured":"Seirafi M, de Vroey B, Amiot A et al. Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease. Aliment Pharmacol Ther. 2014;40:363\u2013373.","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"8016_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/apt.16448","volume":"54","author":"A Meyer","year":"2021","unstructured":"Meyer A, Drouin J, Weill A. Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and\/or anti-TNF: a French nationwide study 2010\u20132018. Aliment Pharmacol Ther. 2021;54:302\u2013311.","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"8016_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jaci.2021.07.005","volume":"148","author":"KM De Felice","year":"2021","unstructured":"De Felice KM, Kane S. Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021;148:661\u2013667.","journal-title":"J Allergy Clin Immunol."},{"issue":"Suppl 1","key":"8016_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000502886","volume":"101","author":"S Restellini","year":"2020","unstructured":"Restellini S, Biedermann L, Hruz P et al. Update on the management of inflammatory bowel disease during pregnancy and breastfeeding. Digestion 2020;101:27\u201342.","journal-title":"Digestion"},{"issue":"1","key":"8016_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/ibd\/izz110","volume":"26","author":"M Julsgaard","year":"2020","unstructured":"Julsgaard M, Hvas CL, Gearry RB et al. Anti-TNF therapy in pregnant women with inflammatory bowel disease: effects of therapeutic strategies on disease behavior and birth outcomes. Inflamm Bowel Dis. 2020;26:93\u2013102.","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"8016_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/14767050410001668662","volume":"15","author":"MC Bush","year":"2004","unstructured":"Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004;15:237\u2013241.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"6","key":"8016_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cgh.2010.02.014","volume":"8","author":"O Stephansson","year":"2010","unstructured":"Stephansson O, Larsson H, Pedersen L et al. Crohn\u2019s disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol. 2010;8:509\u2013515.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"11","key":"8016_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/M14-1884","volume":"161","author":"ML LeFevre","year":"2014","unstructured":"LeFevre ML, Force USPST. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161:819\u2013826.","journal-title":"Ann Intern Med."},{"issue":"7","key":"8016_CR19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/MIB.0b013e318281334d","volume":"19","author":"JD Betteridge","year":"2013","unstructured":"Betteridge JD, Armbruster SP, Maydonovitch C, Veerappan GR. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis. 2013;19:1421\u20131427.","journal-title":"Inflamm Bowel Dis."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08016-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08016-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08016-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:07:40Z","timestamp":1692756460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08016-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["8016"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08016-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"10 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sunanda Kane received consulting fees from Janssen, the manufacturers of an anti-TNF biologic therapy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}